Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs Oatly Group AB - ADR (OTLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs Oatly Group AB - ADR — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $44.17 (market cap $7.10B), while Oatly Group AB - ADR trades at $11.13 (market cap $355.50M). The key difference: Ionis Pharmaceuticals Inc. Common Stock is far larger — about 20× Oatly Group AB - ADR's market cap, and Oatly Group AB - ADR is trading nearer its 52-week high, Ionis Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Oatly Group AB - ADR for 18 Days on average.
| IONS | OTLY | |
|---|---|---|
Market Cap | $7.10B | $355.50M |
Volume | 2,027,457 | 70,853 |
Sector | Health | Consumer Staples |
52-Week High | $86.50 | $15.91 |
52-Week Low | $42.38 | $8.03 |
Typical Hold Time | 0 Days | 18 Days |
Enterprise Value | $6.66B | $859.91M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
OTLY trades at $10.88, up 1.97% today, with a bearish technical signal despite recent positive earnings momentum. The company shows improving revenue growth ($862M in 2025, projected $925M in 2026) and narrowing losses, though profitability remains elusive with a -13.81% net margin. Analyst consensus is mixed with 44% buy ratings and a $12.28 price target, representing 13% upside from current levels.
The stock offers speculative upside if Oatly can achieve its path to profitability, but faces significant execution risks including persistent cash burn, high debt levels, and intense plant-based beverage competition. Investors should weigh the improving operational trends against the company's substantial financial challenges before considering a position.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About Oatly Group AB - ADR
Oatly Group AB is engaged in the food and drinks industry. Some of its products include Oat Drink, Chilled Oat Drink, Oatgurt, Creamy Oat, Icecreams, among others. It caters to Sweden, Germany, United Kingdom, Netherlands, North America, Finland, and other markets.
Read more on OTLY →
